奇异变形杆菌
微生物学
抗菌剂
阴沟肠杆菌
肺炎克雷伯菌
铜绿假单胞菌
抗生素耐药性
生物
猫
肠球菌
中间葡萄球菌
细菌
大肠杆菌
葡萄球菌
医学
抗生素
金黄色葡萄球菌
内科学
基因
生物化学
遗传学
作者
Laila Darwich,Chiara Seminati,Ares Burballa,Alba Nieto,Inma Durán,Núria Tarradas,Rafael A. Molina‐López
摘要
Abstract Background The increasing emergence of multidrug‐resistant bacteria, causing urinary tract infections (UTI) in dogs and cats, represents a great therapeutic challenge and a public health concern. Methods Laboratory records of 4943 urinary microbiological diagnosis results and antimicrobial resistance profiles of suspected UTI cases in dogs and cats were analysed from 2016 to 2018 in Spain. Results This study showed a higher percentage of positive microbiological diagnoses in dogs (42%, 1368/3270) than in cats (27%, 457/1673). Although Escherichia coli was the most frequently isolated bacterium, the frequency of antimicrobial susceptibility of E. coli isolates was lower compared to other bacterial species like Enterococcus spp., Staphylococcus spp., Klebsiella pneumoniae , Pseudomonas aeruginosa , Enterobacter ( E. cloacae ), and Proteus mirabilis . The antimicrobial susceptibility testing of Gram‐positive cocci showed higher levels of resistance in cats to common beta‐lactams used for the treatment of complicated UTIs, as well as to fluoroquinolones, aminoglycosides, and carbapenems. Moreover, enterobacteria ( E. coli , K. pneumoniae , and P. mirabilis ) from cats presented high resistance frequencies to beta‐lactams, including third‐ and fourth‐generation cephalosporins and fluoroquinolones. Conclusion This study updates data on the current antimicrobial resistance in UTI bacteria from companion animals in Spain, which may help to guide clinicians for the appropriate use of antimicrobials.
科研通智能强力驱动
Strongly Powered by AbleSci AI